Oral Wegovy Approved: A New Option for Weight Loss

A new oral version of the weight loss drug Wegovy has been approved by the Food and Drug Administration (FDA), offering a more affordable and accessible alternative to injectable GLP-1 medications. This development could significantly impact the millions of Americans seeking weight loss treatment.

Cost and Accessibility

The oral Wegovy pill is available for as low as $149 a month for the starting dose, potentially even less with insurance coverage. This is a substantial difference compared to the injectable version of Wegovy, which can cost over $1,300 for a 28-day supply without insurance or savings programs. Dr. Celia Egan of True Women’s Health emphasizes that cost has been a major barrier to treatment, and this new option addresses that concern.

How it Works

Unlike injectable GLP-1 drugs, the oral pill is taken once daily and does not require refrigeration. It similarly offers flexibility in managing side effects, such as nausea or diarrhea, by simply skipping a dose. Scientists overcame a significant challenge in developing the oral version: preventing the drug from being broken down by stomach acid. They achieved this by creating a coating that allows the medication to be absorbed in the gastrointestinal tract.

Weight Loss Results

Clinical studies have demonstrated that patients taking the oral GLP-1 lost an average of 16% of their body weight. While slightly less than the 20% weight loss observed with some injectable options, Dr. Egan notes that a 16% reduction is still a meaningful and effective result.

Patient Experiences

Individuals who have been using injectable GLP-1 medications report transformative experiences. Nicole Steensma lost nearly 100 pounds with Zepbound and credits the medication with improving her quality of life, particularly as she remarried. Linda Mohney turned to weight loss medication after struggling with high blood pressure, high cholesterol, and menopause, finding success where other methods had failed. Both women anticipate continuing medication long-term.

Future Developments

Eli Lilly, the manufacturer of Zepbound, is also developing an oral version of its weight loss drug.

Key Takeaways

• The FDA has approved an oral version of Wegovy, providing a more affordable alternative to injections.
• The pill costs approximately $149 per month for the starting dose, significantly less than the injectable version.
• Clinical trials show an average weight loss of 16% with the oral medication.
• The pill is taken once daily and does not require refrigeration.
• Combining medication with healthy lifestyle habits (diet and exercise) is crucial for optimal results.